• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往活检方案对重复活检时检测到的癌症病理特征的影响。

Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.

作者信息

Hong Y Mark, Lai Frank C, Chon Chris H, McNeal John E, Presti Joseph C

机构信息

Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Urol Oncol. 2004 Jan-Feb;22(1):7-10. doi: 10.1016/S1078-1439(03)00147-9.

DOI:10.1016/S1078-1439(03)00147-9
PMID:14969796
Abstract

The object of our study was to characterize the biopsy features of cancers detected in a repeat biopsy population stratified on the basis of the type of prior negative biopsy. We studied 218 patients with a prior negative biopsy who underwent a 10-core extended systematic biopsy scheme, and a subset (n = 139) underwent additional 6 anteriorly directed biopsies. Clinicopathologic features of patients with cancer on the biopsy were compared as a function of type of prior negative biopsy. Overall and unique cancer detection rates were calculated for each of the biopsy sites. Cancer detection rates tended to be higher in patients who had undergone a prior sextant biopsy compared to a prior extended biopsy scheme (39% vs. 28%). Trends towards more positive cores and greater total core length of cancer involvement were seen in patients who had undergone a prior negative sextant biopsy. Apical and laterally directed biopsies had higher overall and unique cancer detection rates in patients who had undergone a prior negative sextant biopsy. Anteriorly directed biopsies had a low unique cancer detection rate in all patients. We conclude that in patients undergoing repeat biopsy, the detection rate is affected by the extent of the prior biopsy. Clinicopathologic features of cancers detected on repeat biopsy tend to be worse in patients who have undergone a prior negative sextant biopsy compared to a negative prior extended biopsy.

摘要

我们研究的目的是描述在根据先前阴性活检类型分层的重复活检人群中检测到的癌症的活检特征。我们研究了218例先前活检为阴性且接受了10针扩展系统活检方案的患者,其中一部分患者(n = 139)还接受了额外的6针前向活检。根据先前阴性活检的类型,对活检发现癌症的患者的临床病理特征进行了比较。计算每个活检部位的总体癌症检出率和独特癌症检出率。与先前接受扩展活检方案的患者相比,先前接受六分区活检的患者的癌症检出率往往更高(39% 对 28%)。在先前六分区活检为阴性的患者中,可见癌灶阳性针数更多、癌灶累及的总针长更长的趋势。在先前六分区活检为阴性的患者中,顶端和侧向活检的总体癌症检出率和独特癌症检出率更高。在前向活检中,所有患者的独特癌症检出率都很低。我们得出结论,在接受重复活检的患者中,检出率受先前活检范围的影响。与先前扩展活检为阴性的患者相比,先前六分区活检为阴性的患者在重复活检时检测到的癌症的临床病理特征往往更差。

相似文献

1
Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.既往活检方案对重复活检时检测到的癌症病理特征的影响。
Urol Oncol. 2004 Jan-Feb;22(1):7-10. doi: 10.1016/S1078-1439(03)00147-9.
2
Use of extended systematic sampling in patients with a prior negative prostate needle biopsy.在既往前列腺穿刺活检结果为阴性的患者中使用扩展系统抽样法。
J Urol. 2002 Jun;167(6):2457-60.
3
No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).对于前列腺特异性抗原(PSA)水平为4.0 ng/mL或更高的男性,初次六分区活检结果为阴性后,无需立即重复进行六分区活检(荷兰鹿特丹欧洲前列腺癌筛查随机对照试验)。
Urology. 2004 May;63(5):892-7; discussion 897-9. doi: 10.1016/j.urology.2003.12.042.
4
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.系统性12针活检对游离前列腺特异性抗原百分比在前列腺癌检测中性能的影响。
J Urol. 2004 Sep;172(3):900-4. doi: 10.1097/01.ju.0000134619.72675.8d.
5
Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.扩展前列腺活检方案提高了 Gleason 分级的可靠性:对放疗患者的影响
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91. doi: 10.1016/j.ijrobp.2003.10.014.
6
Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.根据前列腺体积个体化制定活检方案以检测前列腺癌。
J Urol. 2005 May;173(5):1536-40. doi: 10.1097/01.ju.0000154242.60413.3d.
7
Prostate biopsy: who, how and when. An update.前列腺活检:对象、方法及时机。最新进展。
Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100.
8
Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.在重复活检时诊断出的前列腺癌体积较小,且高级别癌的可能性较低。
J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15.
9
Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.在重复12针活检方案中,外周活检对于最大限度检测早期前列腺癌的重要性。
BJU Int. 2006 Sep;98(3):559-62. doi: 10.1111/j.1464-410X.2006.06325.x.
10
Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?对于血清前列腺特异性抗原>10 ng/ml且先前外周带活检阴性的良性前列腺增生患者,移行区活检是否有价值?
Scand J Urol Nephrol. 2005;39(1):49-55. doi: 10.1080/00365590410002555.

引用本文的文献

1
Lab-in-a-Fiber detection and capture of cells.光纤内实验室对细胞的检测与捕获。
Sci Rep. 2025 Mar 20;15(1):9694. doi: 10.1038/s41598-025-92585-6.
2
Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study).随机研究经直肠和经会阴前列腺活检的疗效和并发症的原理和方案(ProBE-PC 研究)。
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):688-696. doi: 10.1038/s41391-021-00352-1. Epub 2021 Mar 25.
3
Transrectal ultrasound-guided prostate rebiopsy: How many core sampling should be applied to which patient?
经直肠超声引导下的前列腺再次活检:对于不同患者应采用多少针穿刺取样?
Urol Ann. 2018 Jan-Mar;10(1):15-19. doi: 10.4103/UA.UA_110_17.
4
Pain during transrectal ultrasound-guided prostate biopsy and the role of periprostatic nerve block: what radiologists should know.经直肠超声引导下前列腺穿刺活检时的疼痛及前列腺周围神经阻滞的作用:放射科医生应了解的内容。
Korean J Radiol. 2014 Sep-Oct;15(5):543-53. doi: 10.3348/kjr.2014.15.5.543. Epub 2014 Sep 12.
5
Standards for prostate biopsy.前列腺活检标准。
Curr Opin Urol. 2014 Mar;24(2):155-61. doi: 10.1097/MOU.0000000000000031.
6
Significance of atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in prostate biopsy.前列腺活检中非典型小腺泡增生和高级别前列腺上皮内瘤变的意义
Korean J Urol. 2011 Nov;52(11):736-40. doi: 10.4111/kju.2011.52.11.736. Epub 2011 Nov 17.
7
Management of rising prostate-specific antigen after a negative biopsy.前列腺特异性抗原升高患者的管理:阴性前列腺活检结果后的处理
Curr Urol Rep. 2011 Jun;12(3):197-202. doi: 10.1007/s11934-011-0177-1.
8
CUA guidelines on prostate biopsy methodology.加拿大泌尿外科学会前列腺活检方法指南。
Can Urol Assoc J. 2010 Apr;4(2):89-94. doi: 10.5489/cuaj.10021.
9
Strategies for repeat prostate biopsies.重复前列腺活检的策略。
Curr Urol Rep. 2009 May;10(3):172-8. doi: 10.1007/s11934-009-0030-y.
10
Using biopsy to detect prostate cancer.使用活检来检测前列腺癌。
Rev Urol. 2008 Fall;10(4):262-80.